What are the ultrasound features of mastitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ultrasound Features of Mastitis

Mastitis on ultrasound typically demonstrates parenchymal edema, skin thickening, fluid collections/abscesses, and hypoechoic masses, with the combination of collections and parenchymal edema being particularly characteristic of the condition.

Key Ultrasound Findings

Primary Features

The most common and diagnostically useful ultrasound findings in mastitis include 1, 2:

  • Parenchymal edema (48.2% of cases) - appears as diffuse increased echogenicity and tissue thickening
  • Fluid collections/abscesses (66.7% of cases) - ranging from simple to complex fluid collections
  • Skin thickening (21.5% of cases) - diffuse or focal thickening of the breast skin
  • Hypoechoic masses (31.4% of cases) - irregular or ill-defined hypoechoic areas within the parenchyma

Highly Specific Combination

The simultaneous presence of both collections AND parenchymal edema (seen in 32.3% of cases) is particularly useful for differentiating mastitis from other breast lesions 2. This combination may reduce the need for immediate biopsy when clinical symptoms are consistent with mastitis.

Distinguishing Infectious vs Non-Infectious Mastitis

Infectious Mastitis Features 1

  • Diffuse edema with inflammatory changes
  • Diffuse skin thickening
  • Multiple collections or frank abscesses
  • More commonly shows fluid-filled structures

Non-Infectious Mastitis Features 1

  • Typically presents as solitary or multiple discrete breast masses
  • More solid-appearing lesions
  • Less diffuse edema
  • May show complex cystic components 3

Additional Ultrasound Characteristics

Associated Findings 2

  • Axillary lymphadenopathy (50.2% of cases)
    • Cortical thickening present in 61.9% of enlarged nodes
  • Fistulae (5% of cases) - tract-like hypoechoic structures extending to skin
  • Vascular changes - increased vascularity on color Doppler

BI-RADS Classification 2

Most mastitis cases are categorized as:

  • BI-RADS 4 (46.4%) - suspicious abnormality
  • BI-RADS 3 (30.4%) - probably benign

Critical Pitfall: Distinguishing from Malignancy

Mastitis can mimic inflammatory breast cancer both clinically and radiologically 4, 1. Key considerations:

  • Failure to respond to antibiotics after 7-10 days should raise suspicion for malignancy 5
  • Persistent clinical signs despite treatment warrant biopsy
  • Some breast cancers can present with falsely benign-appearing features including circumscribed margins and posterior acoustic enhancement 6
  • When imaging and clinical findings suggest mastitis but are atypical or persistent, core needle biopsy is mandatory to exclude malignancy

Role of Adjunctive Imaging

Strain Elastography 7

  • Improves classification accuracy to 65.8% when combined with conventional ultrasound
  • Helps differentiate mastitis subtypes
  • Mean elastography scores differ significantly between subtypes

Contrast-Enhanced Ultrasound 7

  • Shows hyperenhancement with or without increased lesion size
  • Less useful for subtype classification
  • Cannot reliably distinguish between mastitis types

Mammography

  • Limited role in acute mastitis due to pain and increased breast density 4, 8
  • May show focal asymmetry as the most common finding 1
  • More useful after acute phase resolution

Clinical Algorithm

  1. First-line imaging: Ultrasound is the modality of choice 4, 8
  2. Look for the diagnostic combination: Collections + parenchymal edema
  3. Assess for complications: Abscesses requiring drainage
  4. Evaluate lymph nodes: Check for axillary involvement
  5. If atypical or persistent: Proceed to core needle biopsy regardless of imaging appearance
  6. If no response to antibiotics in 7-10 days: Mandatory biopsy to exclude inflammatory breast cancer 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.